A successful MSL will strengthen the bond between UroGen and the disease area community by being informative to thought leaders with reliable, objective, clinical education, supportive of research endeavors, and receptive to feedback on therapeutic products, clinical trends, and research of interest, through peer-to-peer scientific exchange, and being able to translate this activity and information back into UroGen to align the Company externally. The Field Medical Science Liaison (MSL) is an externally facing role with UroGen Pharma, Inc. responsible for 2-way scientific communication, support and collaboration with therapeutic experts, healthcare providers, researchers, disease-area advocates, and other organizations in the urology and urologic-oncology community.